Gnostic and agnostic immunotherapy by tropism-retargeted herpes simplex virus without direct tumor treatment
Background Cancer immunotherapy includes vaccines generated through distinct approaches, each with advantages and limitations. Those made of autologous or allogeneic whole cells do not require prior identification of antigens, that is, immunize against undetermined (agnostic) tumor antigens. However...
Saved in:
| Main Authors: | Andrea Vannini, Federico Parenti, Cristina Forghieri, Elisabetta Romagnoli, Daniela Massaro, Anna Zaghini, Gabriella Campadelli-Fiume, Tatiana Gianni |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-07-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/7/e011812.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review of Retargeting Methods and Assessment of Retargeted Image Objective Quality
by: MA Qian, DONG Wu, ZENG Qingtao, ZHANG Yan, LU Likun, ZHOU Ziyi
Published: (2025-02-01) -
Herpes Simplex Virus Encephalitis
by: J Gordon Millichap
Published: (1992-04-01) -
Herpes Simplex Encephalitis Relapse
by: J Gordon Millichap
Published: (2003-08-01) -
Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy?
by: Howard L Kaufman, et al.
Published: (2024-05-01) -
Herpes Simplex Esophagitis in Immunocompetent Hosts
by: Daniel Eymard, et al.
Published: (1997-01-01)